| Molecular regulation of vascular smooth muscle cell differentiation in development and disease GK Owens, MS Kumar, BR Wamhoff Physiological reviews 84 (3), 767-801, 2004 | 4165 | 2004 |
| COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options TJ Guzik, SA Mohiddin, A Dimarco, V Patel, K Savvatis, FM Marelli-Berg, ... Cardiovascular research 116 (10), 1666-1687, 2020 | 1734 | 2020 |
| Inflammation, immunity, and hypertension DG Harrison, TJ Guzik, HE Lob, MS Madhur, PJ Marvar, SR Thabet, ... Hypertension 57 (2), 132-140, 2011 | 1023 | 2011 |
| Interleukin 17 promotes angiotensin II–induced hypertension and vascular dysfunction MS Madhur, HE Lob, LA McCann, Y Iwakura, Y Blinder, TJ Guzik, ... Hypertension 55 (2), 500-507, 2010 | 967 | 2010 |
| Inflammation, immunity, and hypertensive end-organ damage WG McMaster, A Kirabo, MS Madhur, DG Harrison Circulation research 116 (6), 1022-1033, 2015 | 804 | 2015 |
| DC isoketal-modified proteins activate T cells and promote hypertension A Kirabo, V Fontana, APC De Faria, R Loperena, CL Galindo, J Wu, ... The Journal of clinical investigation 124 (10), 4642-4656, 2014 | 577 | 2014 |
| The immunology of hypertension AE Norlander, MS Madhur, DG Harrison Journal of Experimental Medicine 215 (1), 21-33, 2018 | 441 | 2018 |
| Activation of human T cells in hypertension: studies of humanized mice and hypertensive humans HA Itani, WG McMaster Jr, MA Saleh, RR Nazarewicz, TP Mikolajczyk, ... Hypertension 68 (1), 123-132, 2016 | 283 | 2016 |
| Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein E–deficient mice MS Madhur, SA Funt, L Li, A Vinh, W Chen, HE Lob, Y Iwakura, Y Blinder, ... Arteriosclerosis, thrombosis, and vascular biology 31 (7), 1565-1572, 2011 | 271 | 2011 |
| Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase J Wu, SR Thabet, A Kirabo, DW Trott, MA Saleh, L Xiao, MS Madhur, ... Circulation research 114 (4), 616-625, 2014 | 263 | 2014 |
| Oligoclonal CD8+ T Cells Play a Critical Role in the Development of Hypertension DW Trott, SR Thabet, A Kirabo, MA Saleh, H Itani, AE Norlander, J Wu, ... Hypertension 64 (5), 1108-1115, 2014 | 262 | 2014 |
| Immune activation caused by vascular oxidation promotes fibrosis and hypertension J Wu, MA Saleh, A Kirabo, HA Itani, KRC Montaniel, L Xiao, W Chen, ... The Journal of clinical investigation 126 (1), 50-67, 2016 | 258 | 2016 |
| Combinatorial control of smooth muscle–specific gene expression MS Kumar, GK Owens Arteriosclerosis, thrombosis, and vascular biology 23 (5), 737-747, 2003 | 233 | 2003 |
| Renal Transporter Activation During Angiotensin-II Hypertension is Blunted in Interferon-γ−/− and Interleukin-17A−/− Mice NV Kamat, SR Thabet, L Xiao, MA Saleh, A Kirabo, MS Madhur, E Delpire, ... Hypertension 65 (3), 569-576, 2015 | 232 | 2015 |
| Role of the adaptive immune system in hypertension DG Harrison, A Vinh, H Lob, MS Madhur Current opinion in pharmacology 10 (2), 203-207, 2010 | 219 | 2010 |
| Interleukin-17A regulates renal sodium transporters and renal injury in angiotensin II–induced hypertension AE Norlander, MA Saleh, NV Kamat, B Ko, J Gnecco, L Zhu, BL Dale, ... Hypertension 68 (1), 167-174, 2016 | 214 | 2016 |
| Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation MA Saleh, WG McMaster, J Wu, AE Norlander, SA Funt, SR Thabet, ... The Journal of clinical investigation 125 (3), 1189-1202, 2015 | 174 | 2015 |
| CD70 exacerbates blood pressure elevation and renal damage in response to repeated hypertensive stimuli HA Itani, L Xiao, MA Saleh, J Wu, MA Pilkinton, BL Dale, NR Barbaro, ... Circulation research 118 (8), 1233-1243, 2016 | 173 | 2016 |
| Hypertension: do inflammation and immunity hold the key to solving this epidemic? MS Madhur, F Elijovich, MR Alexander, A Pitzer, J Ishimwe, ... Circulation research 128 (7), 908-933, 2021 | 169 | 2021 |
| Inhibition of interleukin-17A, but not interleukin-17F, signaling lowers blood pressure, and reduces end-organ inflammation in angiotensin II–induced hypertension MA Saleh, AE Norlander, MS Madhur JACC: Basic to Translational Science 1 (7), 606-616, 2016 | 139 | 2016 |
David G. HarrisonProfessor of Medicine, Vanderbilt UniversityEmail verificata su vanderbilt.edu